HCV Treatment Interruptions: Stop Treatment or Keep Going?

Publish date:
August 03, 2023
South Central AETC Local Partner
AETC Source
South Central AETC, 
University of New Mexico Health Sciences Center, ECHO Institute / Project ECHO - NM Regional Partner

Training slides learning objective include:

  • Applying the guidance provided by the AASLD/IDSA on hepatitis C virus (HCV) direct-acting antiviral (DAA) treatment interruptions
  • Identifying when patients should have DAA therapy continued vs. when DAA therapy should be stopped
  • Describing the data in patients with incomplete

Preview and Download

Browse more